• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PD 198306

CAS No. 212631-61-3

PD 198306 ( —— )

产品货号. M27491 CAS No. 212631-61-3

PD 198306 是一种选择性 MAPK/ERK 激酶 (MEK) 抑制剂,具有抗痛觉过敏作用。 PD 198306 可降低链脲佐菌素 (Streptozocin) 诱导的活性 ERK1 水平的增加。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1912 有现货
10MG ¥2803 有现货
25MG ¥4706 有现货
50MG ¥6715 有现货
100MG ¥9315 有现货
500MG ¥18468 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PD 198306
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PD 198306 是一种选择性 MAPK/ERK 激酶 (MEK) 抑制剂,具有抗痛觉过敏作用。 PD 198306 可降低链脲佐菌素 (Streptozocin) 诱导的活性 ERK1 水平的增加。
  • 产品描述
    PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.(In Vitro):PD 198306 (10?μM) reduces Tha-Crimson replication by 30% at 18?h and 50% at 36?h. PD 198306 (10? μM) significantly inhibits Tha-GFP replication by 25%.(In Vivo):In male Sprague Dawley rats bearing neuropathic pain, PD 198306 (1-30 μg/10 μL; i.t.) dose-dependently blocks static allodynia in both the chronic constriction injury and the streptozocin models.
  • 体外实验
    PD198306 significantly inhibits Tha-GFP replication by 25% at 10?μM, after 36?h.PD198306 (5?μM) reduces Tha-Crimson replication significantly by 20% at 18?h but such a result could not be confirmed at 36?h. Cell Cycle Analysis Cell Line:Human induced pluripotent stem cells (iPSC) Concentration:10? μM Incubation Time:6? hours Result:Inhibited Tha-Crimson replication at 10?μM, reducing it by 30% at 18?h and 50% at 36?h.
  • 体内实验
    Intrathecal administration of PD 198306 (1-30 μg per 10 μL) dose-dependently (1-30 μg) blocks static allodynia in both the streptozocin and the chronic constriction injury (CCI) models of neuropathic pain. Animal Model:Male Sprague Dawley rats (250-300 g) bearing neuropathic pain Dosage:1-30 μg per 10 μL and 3 mg per 100 μL (PD 198306 is suspended in cremophor:ethanol:water, 1 : 1 : 8.)Administration:Single doses of intrathecal (i.t.) or intraplantar (ipl) of PD 198306 (1-30 μg per 10 μL and 3 mg per 100 μL respectively Result:Intrathecal administration dose-dependently (1-30 μg) blocked static allodynia the streptozocin model of neuropathic pain. The minimum effective doses (MED) of 3 μg significantly blocked static allodynia 30 min after treatment. Both 10 μg and the highest dose used (30 μg) totally blocked the maintenance of static allodynia, for up to 1 h.
  • 同义词
    ——
  • 通路
    MAPK/ERK Signaling
  • 靶点
    MEK
  • 受体
    Acidic mammalian chitinase (AMCase)|Bacterial|GH18 chitinase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    212631-61-3
  • 分子量
    476.23
  • 分子式
    C18H16F3IN2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=C(NOCC1CC1)C2=CC(F)=C(F)C(F)=C2NC3=CC=C(I)C=C3C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Schüttelkopf AW, et al. Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases. ACS Med Chem Lett. 2011;2(6):428-432. Published 2011 Mar 23.
产品手册
关联产品
  • RO-5126766

    一种强效、一流的双重 Raf/MEK 抑制剂,对 C-Raf/MEK1 的 IC50 为 56 nM/160 nM。

  • MAP3K14-IN-173

    一种新型有效的 MAP3K14 激酶抑制剂,IC50 为 1.8 nM(NIK 自磷酸化)。

  • Binimetinib

    Binimetinib (MEK162、ARRY-162、ARRY-438162) 是一种有效的 MEK1/2 抑制剂,在无细胞测定中 IC50 为 12 nM。